Madison Dearborn Partners has completed its acquisition of the medical business of Patterson Companies for approximately $715 million in cash.
Patterson Medical was founded in 1995 as Sammons Preston and was later renamed AbilityOne. The company was acquired by Patterson Companies in 2003. Today, Patterson Medical is a global specialty distributor of rehabilitation supplies and equipment to acute care facilities, outpatient clinics, and long-term care facilities. The business has approximately 20,000 SKUs of rehabilitation supplies, equipment and assisted living products.
Patterson Medical also has a sports medicine division which operates under the Medco brand name and distributes more than 12,000 SKUs to athletic trainers in professional sports, high school and college teams and recreational sports organizations. In fiscal 2015, Patterson Medical had total sales of $464 million and EBITDA of $67 million (EBITDA margin of 14.4%). Patterson Medical is headquartered in the Chicago suburb of Warrenville, IL (www.pattersonmedical.com).
The current Patterson Medical management team, including CEO Michael Orscheln will continue in their current positions. Patterson Medical will retain its name for a transition period but will be rebranded by Madison Dearborn Partners.
“Patterson Medical is a leader in its field and has strong competitive advantages and we are pleased to partner with the company’s exceptional management team,” said Tim Sullivan, a managing director at Madison Dearborn. “Madison Dearborn has experience investing in health care distribution companies and corporate carve-outs, and we plan to utilize our resources and expertise to support Patterson Medical’s US and international growth.”
Madison Dearborn Partners has more than $18 billion of capital under management. Sectors of interest include health care; basic industries; business and government services; consumer; financial and transaction services; and telecom, media and technology services. Madison Dearborn was founded in 1992 and is based in Chicago (www.mdcp.com).
Earlier this year, Patterson Companies (NASDAQ:PDCO) retained BofA Merrill Lynch to explore the sale of its medical business. Patterson will use the proceeds from the sale to reduce the debt it incurred to fund its $1.1 billion acquisition in June 2015 of Animal Health International, a distributor of vaccines and pharmaceuticals, equipment and software used to treat the health needs of companion animals, equine, beef and dairy cattle, poultry and swine. “The sale of the medical business accomplishes a key component of Patterson’s strategic transformation,” said Scott Anderson, Patterson’s CEO. “We are now positioned to focus on developing our dental and animal health businesses.”
Madison Dearborn was advised by Barclays and Deutsche Bank and Kirkland & Ellis acted as legal advisor. Deutsche Bank, Barclays, BofA Merrill Lynch and Jefferies provided debt financing to support the acquisition.
BofA Merrill Lynch acted as financial advisor and Briggs and Morgan acted as legal advisor to Patterson Companies.
© 2015 PEPD • Private Equity’s Leading News Magazine • 8-31-15